Shipping to United States We Offer Worldwide Shipping
Login Wishlist

5,7,4’-Trihydroxy-8-methylflavanone

$941

  • Brand : BIOFRON

  • Catalogue Number : BD-P0060

  • Specification : 99.0%(HPLC)

  • CAS number : 916917-28-7

  • Formula : C16H14O5

  • Molecular Weight : 286.08

  • PUBCHEM ID : 16094542

  • Volume : 25mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BD-P0060

Analysis Method

HPLC,NMR,MS

Specification

99.0%(HPLC)

Storage

2-8°C

Molecular Weight

286.08

Appearance

Powder

Botanical Source

Structure Type

Flavonoids

Category

SMILES

CC1=C(C=C(C2=C1OC(CC2=O)C3=CC=C(C=C3)O)O)O

Synonyms

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methyl-2,3-dihydrochromen-4-one

IUPAC Name

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methyl-2,3-dihydrochromen-4-one

Applications

Density

1.4±0.1 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

218.1±23.6 °C

Boiling Point

570.2±50.0 °C at 760 mmHg

Melting Point

InChl

InChI=1S/C16H14O5/c1-8-11(18)6-12(19)15-13(20)7-14(21-16(8)15)9-2-4-10(17)5-3-9/h2-6,14,17-19H,7H2,1H3

InChl Key

GMVYLXBMPRDZDR-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

2933990000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:916917-28-7) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

23507726

Abstract

The state-of-the-art of biocomposites and hybrid biomaterials based on calcium orthophosphates that are suitable for biomedical applications is presented in this review. Since these types of biomaterials offer many significant and exciting possibilities for hard tissue regeneration, this subject belongs to a rapidly expanding area of biomedical research. Through successful combinations of the desired properties of matrix materials with those of fillers (in such systems, calcium orthophosphates might play either role), innovative bone graft biomaterials can be designed. Various types of biocomposites and hybrid biomaterials based on calcium orthophosphates, either those already in use or being investigated for biomedical applications, are extensively discussed. Many different formulations, in terms of the material constituents, fabrication technologies, structural and bioactive properties as well as both in vitro and in vivo characteristics, have already been proposed. Among the others, the nanostructurally controlled biocomposites, those containing nanodimensional compounds, biomimetically fabricated formulations with collagen, chitin and/or gelatin as well as various functionally graded structures seem to be the most promising candidates for clinical applications. The specific advantages of using biocomposites and hybrid biomaterials based on calcium orthophosphates in the selected applications are highlighted. As the way from the laboratory to the hospital is a long one, and the prospective biomedical candidates have to meet many different necessities, this review also examines the critical issues and scientific challenges that require further research and development.

KEYWORDS

biocomposites, biomedical applications, bone grafts, calcium orthophosphates, hybrid biomaterials, hydroxyapatite, tissue engineering

Title

Biocomposites and hybrid biomaterials based on calcium orthophosphates

Author

Sergey V. Dorozhkin † *

Publish date

2011 Jul 1;